Evidence map›Paper›PMID 35111382›Full record

ArticleInternational journal of burns and trauma2021

Evaluation of the efficacy of Agicoat in the treatment of partial-thickness skin graft donor sites of burn patients.

Hossein Abdollahi Veshnavei

Open access · greenAbstract read
In one paragraph

Article in International journal of burns and trauma, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Hossein Abdollahi VeshnaveiSchool of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.
Isfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBurns is the most common condition that requires extensive skin grafting. Treatment of burns is associated with long hospital stays, expensive medications, multiple surgeries, and long-term rehabilitation. Rapid healing of skin donor areas in partial-thickness burn wounds is important for the patient. Partial-thickness skin grafting is a technique that can reduce healing time and improve the treatment. Nanocrystalline silver contains antibacterial and anti-inflammatory properties. This study aimed to evaluate the efficacy of Agicoat in the treatment of partial-thickness skin graft donor sites of burn patients in terms of healing time, pain and scarring.

methodThis clinical trial study was performed on 100 patients who burn and were referred to Imam Khomeini Hospital in Tehran from July to January 2020. Patients with second- and third-degree burns who had burned 10 to 30 percent of their body surface and required partial-thickness skin graft surgery, were considered for this study. Each patient was compared to herself. The skin donor site was then randomly divided into three parts A, B and C and each part was dressed with Agicoat

resultComparison of the average healing time between groups showed that the average healing time in both groups was significantly shorter than the Vaseline group (P=0.005). Comparison of wound pain between groups on Day 4 showed that the mean pain in the Agicoat group and also the Mepitel group was significantly lower than the Vaseline group (P=0.004). However, Agicoat and Mepitel groups did not show a significant difference. Also, a comparison of pain between groups on Day 8 and the mean VAS six months after skin graft showed no difference between groups.

conclusionAccording to the findings of this study, if the Agicoat dressing is cost-effective, it can be a good alternative to cover the wound of the skin donor site, and it heals faster and reduces pain.

Indexed as

AgicoatBurnskin graft

Identifiers

PMID35111382
PMCPMC8784746
OpenAlexW4210821332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.